Iperionx revenue and financials
Fiscal year ending in June. Sources and method on the page How we analyse stocks.
How Iperionx is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Shares outstanding up 388.0% in 5 years
Average diluted shares, 2021 → 2026: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 0 of 5 fiscal years
Positive net income, fiscal years 2022–2026.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | — | — | 0.0 | 0.0 | 0.0 | — | — | — | — | — |
| Selling, general and administrative | 44.3 | 25.5 | 13.7 | 12.1 | 20.8 | 8.8 | 0.5 | 0.6 | 1.0 | 0.4 |
| Research and development | 25.2 | 12.6 | 8.7 | 5.6 | 1.1 | — | — | — | — | — |
| Operating income | -69.7 | -39.3 | -22.6 | -17.7 | -21.9 | -8.8 | -0.6 | -0.6 | -1.0 | -0.4 |
| EBIT | -69.7 | -39.3 | -22.6 | -17.7 | -21.9 | -8.8 | -0.6 | -0.6 | -1.0 | -0.4 |
| EBITDA | -66.1 | -37.8 | -22.5 | -17.5 | -21.8 | -8.8 | -0.6 | — | — | — |
| Interest expense | 0.3 | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | — | — | — |
| Pre-tax income | -66.8 | -35.3 | -21.8 | -17.4 | -21.5 | -14.4 | -0.5 | -0.5 | -1.0 | -0.4 |
| Income tax | — | — | 0.0 | 0.0 | 0.0 | — | — | — | — | — |
| Net income | -66.8 | -35.3 | -21.8 | -17.4 | -21.5 | -14.4 | -0.5 | -0.5 | -1.0 | -0.4 |
| Net income to common shareholders | -66.8 | -35.3 | -21.8 | -17.4 | -21.5 | -14.4 | -0.5 | -0.5 | -1.0 | -0.4 |
| Basic EPS | -0.20 | -0.12 | -0.10 | -0.10 | -0.16 | -0.21 | -0.02 | -0.02 | -0.11 | -0.15 |
| Diluted EPS | -0.20 | -0.12 | -0.10 | -0.10 | -0.16 | -0.21 | -0.02 | -0.02 | -0.11 | -0.15 |
| Average shares (basic) | 336 | 297 | 218 | 168 | 135 | 68.8 | 31.3 | 30.9 | 8.8 | 3.0 |
| Average shares (diluted) | 336 | 297 | 218 | 168 | 135 | 68.8 | 31.3 | 30.9 | 8.8 | 3.0 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Selling, general and administrative | 11.9 | 17.9 | 7.6 | 5.4 | 4.2 | 3.8 | 3.2 | 3.5 | 3.8 | 2.5 |
| Research and development | 14.4 | 10.8 | 5.8 | 6.8 | 4.9 | 3.8 | 3.5 | 2.1 | 0.4 | 0.7 |
| Operating income | -33.1 | -36.6 | -18.7 | -20.5 | -12.5 | -10.1 | -9.0 | -8.7 | -11.2 | -10.7 |
| EBIT | -33.1 | -36.6 | -18.7 | -20.5 | -12.5 | -10.1 | -9.0 | -8.7 | -11.2 | -10.7 |
| EBITDA | -31.1 | -35.0 | -17.6 | -20.2 | -12.5 | -10.0 | -8.8 | -8.7 | -11.1 | -10.7 |
| Interest expense | — | 1.4 | 2.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| Pre-tax income | -32.0 | -34.8 | -19.1 | -16.2 | -11.3 | -10.5 | -8.7 | -8.8 | -11.0 | -10.6 |
| Net income | -32.0 | -34.8 | -19.1 | -16.2 | -11.3 | -10.5 | -8.7 | -8.8 | -11.0 | -10.6 |
| Net income to common shareholders | -32.0 | -34.8 | -19.1 | -16.2 | -11.3 | -10.5 | -8.7 | -8.8 | -11.0 | -10.6 |
| Basic EPS | -0.10 | -0.10 | -0.06 | -0.06 | -0.05 | -0.05 | -0.05 | -0.06 | -0.08 | -0.08 |
| Diluted EPS | -0.10 | -0.10 | -0.06 | -0.06 | -0.05 | -0.05 | -0.05 | -0.06 | -0.08 | -0.08 |
| Average shares (basic) | 324 | 348 | 323 | 271 | 226 | 210 | 190 | 146 | 137 | 132 |
| Average shares (diluted) | 324 | 348 | 323 | 271 | 226 | 210 | 190 | 146 | 137 | 132 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 106 | 105 | 55.4 | 22.8 | 9.9 | 2.8 | 2.1 | 2.5 | 3.2 | 0.0 |
| Current assets | 44.0 | 58.9 | 41.5 | 12.8 | 5.8 | 1.7 | 1.2 | 1.8 | 2.8 | 0.0 |
| Cash and equivalents | 35.2 | 54.8 | 33.2 | 11.9 | 5.7 | 1.7 | 1.1 | 1.7 | 2.7 | — |
| Receivables | 3.3 | 0.8 | 2.3 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
| Inventory | 3.9 | — | 0.0 | 0.0 | — | — | — | — | — | — |
| Net property, plant and equipment | 49.0 | 31.7 | 13.9 | 7.0 | 3.8 | 1.0 | 0.9 | 0.8 | 0.4 | — |
| Other intangible assets | 12.3 | 13.6 | — | — | — | — | — | — | — | — |
| Long-term investments | — | — | — | 0.0 | 0.3 | — | — | — | — | — |
| Current liabilities | 13.6 | 8.4 | 3.1 | 1.6 | 2.1 | 0.6 | 0.1 | 0.0 | 0.2 | 0.1 |
| Accounts payable | 8.7 | 6.0 | 1.3 | 0.7 | 1.7 | 0.3 | 0.0 | 0.0 | 0.1 | — |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — |
| Total debt | 4.2 | 3.9 | 1.5 | 1.0 | 0.5 | 0.5 | 0.0 | — | — | — |
| Total liabilities | 17.5 | 12.6 | 4.1 | 2.2 | 2.5 | 1.0 | 0.1 | 0.0 | 0.2 | 0.1 |
| Total equity (incl. minority) | 88.3 | 92.4 | 51.3 | 20.6 | 7.4 | 1.8 | 2.0 | 2.5 | 3.0 | -0.1 |
| Retained earnings | -176 | -109 | -73.9 | -52.2 | -34.8 | -13.2 | -2.0 | -1.5 | -1.0 | -0.1 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 106 | 129 | 105 | 116 | 55.4 | 34.0 | 22.8 | 18.0 | 9.9 | 16.2 |
| Current assets | 44.0 | 69.6 | 58.9 | 78.8 | 41.5 | 23.6 | 12.8 | 11.8 | 5.8 | 14.3 |
| Cash and equivalents | 35.2 | 65.8 | 54.8 | 77.1 | 33.2 | 17.3 | 11.9 | 11.4 | 5.7 | 14.3 |
| Receivables | 3.3 | 1.2 | 0.8 | 1.0 | 2.3 | 2.7 | 0.2 | 0.1 | 0.0 | 0.0 |
| Inventory | 3.9 | 0.4 | — | — | 0.0 | — | — | — | — | — |
| Net property, plant and equipment | 49.0 | 43.5 | 31.7 | 22.5 | 13.9 | 10.5 | 7.0 | 6.2 | 3.8 | 1.6 |
| Other intangible assets | 12.3 | 12.9 | 13.6 | 14.1 | — | — | — | — | — | — |
| Long-term investments | — | — | — | — | — | — | — | — | — | 0.3 |
| Current liabilities | 13.6 | 17.3 | 8.4 | 6.7 | 3.1 | 2.6 | 1.6 | 1.8 | 2.1 | 0.6 |
| Accounts payable | 8.7 | 5.2 | 6.0 | 1.5 | 1.3 | 1.1 | 0.7 | 0.4 | 1.7 | 0.6 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Total debt | 4.2 | 4.5 | 3.9 | 4.2 | 1.5 | — | — | — | — | — |
| Total liabilities | 17.5 | 21.0 | 12.6 | 10.3 | 4.1 | 3.9 | 2.2 | 2.6 | 2.5 | 1.1 |
| Total equity (incl. minority) | 88.3 | 108 | 92.4 | 106 | 51.3 | 30.2 | 20.6 | 15.4 | 7.4 | 15.1 |
| Retained earnings | -176 | -144 | -109 | -90.1 | -73.9 | -62.7 | -52.2 | -43.5 | -34.8 | -23.8 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -45.0 | -21.8 | -18.6 | -15.9 | -12.1 | -3.9 | -0.4 | -0.5 | -0.2 |
| Depreciation and amortization | 4.3 | 2.3 | 0.6 | 0.4 | 0.2 | 0.0 | 0.0 | — | — |
| Capital expenditure | -19.0 | -17.6 | -8.1 | -2.7 | -2.8 | -0.6 | -0.1 | -0.4 | -0.0 |
| Investing cash flow | -18.6 | -24.3 | -6.5 | -5.7 | -3.1 | -0.6 | -0.1 | -0.4 | -0.1 |
| Financing cash flow | 43.2 | 68.0 | 46.6 | 27.9 | 19.4 | 6.4 | -0.0 | 0.1 | 3.0 |
| Debt issued | — | — | 0.0 | 0.0 | 0.0 | — | — | — | — |
| Debt repaid | -1.3 | -0.5 | -0.4 | -0.5 | -0.1 | -0.0 | -0.0 | — | -0.2 |
| Effect of exchange rates | 0.8 | -0.3 | -0.2 | -0.1 | -0.2 | -0.0 | — | — | — |
| Net change in cash | -19.6 | 21.7 | 21.2 | 6.3 | 4.0 | 1.9 | -0.6 | -0.8 | 2.7 |
| Free cash flow | -64.0 | -39.4 | -26.7 | -18.6 | -15.0 | — | — | — | — |
| Levered free cash flow | -45.1 | -27.5 | -24.1 | -12.1 | -6.7 | 4.4 | -0.4 | -0.8 | 0.0 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -28.3 | -16.7 | -10.0 | -11.7 | -10.6 | -8.0 | -8.3 | -7.6 | -6.2 | -5.9 |
| Depreciation and amortization | 2.4 | 2.0 | 2.3 | — | 0.6 | — | 0.4 | — | 0.2 | — |
| Capital expenditure | -3.6 | -15.4 | -13.1 | -4.5 | -3.2 | -4.8 | -1.1 | -1.6 | -2.3 | -0.5 |
| Investing cash flow | -2.2 | -16.4 | -13.3 | -11.0 | -1.7 | -4.8 | -4.1 | -1.6 | -2.3 | -0.7 |
| Financing cash flow | -0.7 | 43.9 | -0.2 | 68.2 | 28.4 | 18.2 | 13.0 | 14.9 | 0.1 | 19.3 |
| Dividends paid | — | 0.0 | — | — | — | — | — | — | — | — |
| Share repurchases | -0.0 | — | — | — | — | — | — | — | — | — |
| Debt issued | — | 0.0 | — | — | — | — | — | — | 0.0 | — |
| Debt repaid | -0.7 | -0.6 | -0.2 | -0.3 | -0.2 | -0.2 | -0.2 | -0.3 | -0.1 | -0.0 |
| Effect of exchange rates | 0.6 | 0.2 | 1.3 | -1.5 | -0.2 | -0.0 | -0.1 | 0.0 | -0.1 | -0.1 |
| Net change in cash | -30.6 | 11.0 | -22.3 | 44.0 | 15.8 | 5.4 | 0.5 | 5.8 | -8.6 | 12.6 |
| Free cash flow | -31.9 | -32.1 | -23.2 | -16.2 | -13.9 | -12.8 | -9.4 | -9.2 | -8.6 | -6.4 |
| Levered free cash flow | -20.1 | -24.9 | -20.7 | -6.8 | -9.5 | -14.6 | -6.0 | -6.1 | -4.3 | -2.4 |
Financial statements of similar companies
Companies in the group: same industry, similar size
